Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture

Details for Australian Patent Application No. 2002338667 (hide)

Owner Chiron Behring GmbH & Co.

Inventors Frech, Christian; Gregersen, JensPeter; Lubben, Holger; Vorlop, Jurgen

Agent FB Rice

Pub. Number AU-B-2002338667

PCT Number PCT/EP02/10208

PCT Pub. Number WO2003/023021

Priority 101 44 906.2 12.09.01 DE

Filing date 11 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 2 October 2008

International Classifications

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 101 44 906.2 12.09.01 DE

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002338667

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

10 July 2008 Section 223 Application Received

  Chiron Behring GmbH & Co. An application to extend the time from 11 Sep 2007 to 11 Nov 2008 in which to pay a continuation fee has been filed . Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2005

28 August 2008 Section 223 Application Allowed

  Chiron Behring GmbH & Co. The time in which to pay a continuation fee has been extended to 11 Nov 2008. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2005

2 October 2008 Application Accepted

  Published as AU-B-2002338667

29 January 2009 Standard Patent Sealed

23 April 2009 Alteration of Name

  The name of the patentee has been altered to Noartis Vaccines and Diagnostics GmbH & Co. KG

21 May 2009 Corrigenda

  Change of Names(s) of Applicant(s), Section 104 - 2002 Under the name Noartis Vaccines and Diagnostics GmbH & Co. KG, Application No. 2002338667, under INID (71), correct the name to read Novartis Vaccines and Diagnostics GmbH & Co. KG

14 July 2011 Alteration of Name

  The name of the patentee has been altered to Novartis Vaccines and Diagnostics GmbH 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002338668-Wind turbine power module mounted on the tower foundation

2002338666-Multiplication of viruses in a cell culture